000 01300 a2200337 4500
005 20250517034713.0
264 0 _c20160926
008 201609s 0 0 eng d
022 _a1940-4034
024 7 _a10.1177/1074248415590196
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSleder, Anna T
245 0 0 _aCardiovascular Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics for the Clinical Practitioner.
_h[electronic resource]
260 _bJournal of cardiovascular pharmacology and therapeutics
_cJan 2016
300 _a20-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review
650 0 4 _aBiotransformation
_xgenetics
650 0 4 _aCardiovascular Agents
_xadverse effects
650 0 4 _aCardiovascular Diseases
_xdiagnosis
650 0 4 _aDrug Interactions
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
_xgenetics
650 0 4 _aGenotype
650 0 4 _aHumans
650 0 4 _aPharmacogenetics
650 0 4 _aPhenotype
650 0 4 _aRisk Factors
700 1 _aKalus, James
700 1 _aLanfear, David E
773 0 _tJournal of cardiovascular pharmacology and therapeutics
_gvol. 21
_gno. 1
_gp. 20-6
856 4 0 _uhttps://doi.org/10.1177/1074248415590196
_zAvailable from publisher's website
999 _c24963022
_d24963022